Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Who May Qualify: - Type 2 diabetes under treatment with HbA1c 6.0-10.0% at screening visit - Male or female of 20 years or over - Mixed dyslipidemia: triglyceride 200\~499 mg/dL, HDL-cholesterol male ≤45 mg/dL or female ≤50 mg/dL - Identified carotid artery plaque: carotid intima-media thickness (cIMT) ≥ 1.0 mm - Creatinine ≤1.8 mg/dL Who Should NOT Join This Trial: - Dyslipidemia which requires other therapy: triglyceride ≥500 mg/dL or LDL-cholesterol ≥190 mg/dL - Uncontrolled hypertension - Severe renal dysfunction - GOT/GPT \>120/120 or chronic liver disease - Pregnant or childbearing woman who does not have enough contraception - Changes of medication related to chronic diseases (diabetes, hypertension, dyslipidemia, etc.) within 3 months - Other antiplatlet medication such as cilostazol, clopidogrel (except aspirin) Always talk to your doctor about whether this trial is right for you.